Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties

Journal of Immunological Methods

Volumn 363, Issue 1, 2010, Pages 80-89

  Hartmann, Isabel ^a   Hollweck, Trixi ^a   Haffner, Silvia ^a   Krebs, Michaela ^a   Meiser, Bruno ^a   Reichart, Bruno ^a   Eissner, Günther ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Differentiation; Mixed lymphocyte reaction; Prostaglandin E2; Serum free; Transwell system; Xeno free

Indexed keywords

MATRIGEL; PROSTAGLANDIN E2; VON WILLEBRAND FACTOR;

ADIPOCYTE; ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD; UMBILICAL CORD TISSUE MESENCHYMAL STEM CELL;

ADIPOGENESIS; ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; OSTEOGENESIS; SERUM; UMBILICAL CORD;

BOVINAE;

EID: 78649707114     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.10.008     Document Type: Article

References (32)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815.
2. Angulo R., Fulcher D.A. Measurement of Candida-specific blastogenesis: comparison of carboxyfluorescein succinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expression. Cytometry 1998, 34:143.
3. Breitbach M., Bostani T., Roell W., Xia Y., Dewald O., Nygren J.M., Fries J.W., Tiemann K., Bohlen H., Hescheler J., Welz A., Bloch W., Jacobsen S.E., Fleischmann B.K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007, 110:1362.
4. Campard D., Lysy P.A., Najimi M., Sokal E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008, 134:833.
5. Chen M.-Y., Lie P.-L., Li Z.-L., Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 2009, 37:629.
6. Covas D.T., Siufi J.L.C., Orellama M.D. Isolation and culture of umbilical vein mesenchymal stem cells. Braz. J. Med. Biol. Res. 2003, 36:1179.
7. Di Nicola M., Carlo-Stella C., Magni M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838.
8. Groh M.E., Maitra B., Szekely E., Koc O.N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 2005, 33:928.
9. Haack-Sorensen M., Friis T., Bindslev L., Mortensen S., Johnsen H.E., Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand. J. Clin. Lab. Investig. 2008, 68:192.
10. Horwitz E.M., Le B.K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., Deans R.J., Krause D.S., Keating A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393.
11. Kestendjieva S., Kyurkchiev D., Tsvetkova G., Mehandjiev T., Dimitrov A., Nikolov A., Kyurkchiev S. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol. Int. 2008, 32:724.
12. Kunter U., Rong S., Boor P., Eitner F., Muller-Newen G., Djuric Z., van Roeyen C.R., Konieczny A., Ostendorf T., Villa L., Milovanceva-Popovska M., Kerjaschki D., Floege J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 2007, 18:1754.
13. LeBlanc K., Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005, 7:36.
14. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stem cells. Blood 2007, 110:3499.
15. Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., Haimovitz-Friedman A., Cordon-Cardo C., Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293:293.
16. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143.
17. Prasanna S.J., Gopalakrishnan D., Shankar S.R., Vasandan A.B. Pro-inflammatory cytokines, IFN-γ and TNF-α, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS ONE 2010, 5:e9016.
18. Rachakatla R.S., Marini F., Weiss M.L., Tamura M., Troyer D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 2007, 14:828.
19. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., Zhao R.C., Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 3:141.
20. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative source of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21:105.
21. Ryan J.M., Barry F.P., Murphy J.M., Mahon B.P. Mesenchymal stem cells avoid allogeneic rejection. J. Inflamm. (Lond) 2005, 2:8.
22. Schallmoser K., Rohde E., Bartmann C., Obenauf A.C., Reinisch A., Strunk D. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Biomed. Mater. Eng. 2009, 19:271.
23. Sensebé L., Krampera M., Schrezenmeier H., Bourin P., Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010, 98:93.
24. Seshareddy K., Troyer D., Weiss M.L. Method to isolate mesenchymal-like cells from Wharton's jelly of umbilical cord. Meth. Cell Biol. 2008, 86:101.
25. Troyer D.L., Weiss M.L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008, 26:591.
26. Wagner D.D., Olmsted J.B., Marder V.J. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell Biol. 1982, 95:355.
27. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., Fu Y.S., Lai M.C., Chen C.C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330.
28. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781.
29. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., Troyer D., McIntosh K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865.
30. Wu K.H., Zhou B., Lu S.H., Feng B., Yang S.G., Du W.T., Gu D.S., Han Z.C., Liu Y.L. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J. Cell. Biochem. 2007, 100:608.
31. Xu G., Zhang L., Ren G., Yuan Z., Zhang Y., Zhao R.C., Shi Y. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 2007, 17:240.
32. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived of adult human tissues. Cell. Immunol. 2009, 259:150.